Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

MedPharm Iowa to Produce Medical Cannabidiol in Des Moines, Iowa

11/29/2017
Iowa Department of Public Health issued a notice of intent to award a manufacturing license for MedPharm Iowa to produce medical cannabidiol in Des Moines.

According to company officials, MedPharm Iowa will innovate, manufacture and formulate medical cannabidiol. The newly formed Iowa company is owned by Dr. Chris Nelson, President & CEO of Kemin Industries, a global ingredient company headquartered in Des Moines.

MedPharm will have a state-of-the-art growing and manufacturing facility located on the Kemin campus in Des Moines, and will be investing millions of dollars into the state of Iowa. The Iowa-based company will be obtaining intellectual property from MedPharm Colorado, a Denver-based company specializing in phytopharmaceuticals.

"With the creation of MedPharm Iowa, we will use our innovative expertise and experience with scientifically sound research to assist those dealing with chronic pain, cancer, debilitating diseases and possibly help alleviate the opioid epidemic in Iowa," said Dr. Nelson.

"For more than five decades, the Nelson family has owned and operated Kemin, and we have dedicated our careers to improving the quality of life for billions of people around the world," Dr. Nelson said.

A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.

According to company officials, guided by Dr. Nelson MedPharm Iowa will work to standardize the extraction and manufacturing processes, add scientific rigor to innovation and serve an unmet need in the Iowa market for medical cannabidiol. MedPharm Iowa will have an agreement in place with Kemin to contract for a range of services.

"The Nelson family believes the answers to the world's problems exist in nature and science, and we are determined to find those solutions with extensive research and thoughtful product development," said Dr. Nelson. "I believe botanicals, including the cannabis plant, offer endless possibilities. It is only with innovative vigor and established good manufacturing practices that such botanicals can make an impact to improve lives. MedPharm Iowa aspires to improve the quality of life for those in Iowa who seek natural, scientifically proven solutions to improve daily life when dealing with debilitating medical conditions."

According to Iowa law, MedPharm Iowa must start supplying medical cannabidiol by December 1, 2018.

Share

Exclusive Research